نتایج جستجو برای: desferrioxamine

تعداد نتایج: 929  

2012
Panagiotis Varsos Constantinos Nastos Nikolaos Papoutsidakis Konstantinos Kalimeris George Defterevos Tzortzis Nomikos Agathi Pafiti George Fragulidis Emmanuel Economou Georgia Kostopanagiotou Vassilios Smyrniotis Nikolaos Arkadopoulos

Introduction. Pancreatic injury can manifest after major hepatectomy under vascular control. The main mechanism involved seems to be remote oxidative injury due to "spillage" of reactive oxygen species and cytokines from the liver. The aim of this study is to evaluate the role of desferrioxamine in the prevention of pancreatic injury following major hepatectomy. Methods. Twelve Landrace pigs we...

Journal: :Gut 1997
W C Tan N Krasner P O'Toole M Lombard

BACKGROUND Aminolaevulinic acid (ALA) is an endogenous substrate in the haem biosynthetic pathway. Protoporphyrin IX (PPIX), the immediate haem precursor in the pathway, has photoexcitable properties. Exogenous ALA has been used previously as a precursor agent in photodynamic therapy (PDT). Its main advantage is a short half-life and hence reduced incidence of skin photosensitivity. ALA can be ...

Journal: :British medical journal 1986
H Y Chiu D M Flynn A V Hoffbrand D Politis

Yersinia enterocolitica commonly causes fever and mild gastroenteritis' but occasionally causes severe illness, particularly in patients with iron overload in whom its virulence is enhanced.2 Desferrioxamine used therapeutically may potentiate the growth of yersinia, which uses desferrioxamine as a siderophore to chelate iron.3 We describe three patients with transfusional haemosiderosis and in...

Journal: :The British journal of ophthalmology 1980
S S Declercq

Fourteen rabbits received an intravitreal iron foreign body and were treated with desferrioxamine. Their electroretinographic (ERG) values were recorded and compared with those of an untreated group. With desferrioxamine treatment a delay of the siderotic damage and preservation of better ERG potentials is observed.

Journal: :The Biochemical journal 1988
S Roberts A Bomford

In this study we have determined whether desferrioxamine can chelate iron delivered to human leukaemic cells by the transferrin endocytic cycle. The cellular uptake of desferrioxamine was investigated by an indirect method in which the conversion of repeated pulses of [59Fe]transferrin to [59Fe]ferrioxamine was determined at two concentrations of the drug. Maximum generation of [59Fe]ferrioxami...

2015
Antonella Meloni Mari Giovanna Neri Chiara Tudisca Elisabetta Chiodi Antonino Vallone Daniele De Marchi Roberta Renni Carmelo Fidone Vincenzo Positano Alessia Pepe

Background In thalassemia intermedia (TI) patients no observational study prospectively evaluated in the real life the efficacy of the desferrioxamine (DFO) therapy in removing or preventing myocardial iron overload. The efficacy endpoint of this study is represented by the changes in cardiac T2* values and left ventricular (LV) function parameters in non-transfusion dependent (NTD) TI patients...

Journal: :The Medical journal of Malaysia 2005
B Atas H Caksen O Tuncer A F Oner E Kirimi S Akbayram

In this article, we present an 18-month-old girl with acute iron poisoning who died from acute respiratory distress syndrome due to overdose of desferrioxamine. Our purpose is to emphasize the importance of close follow-up children with acute iron poisoning for desferrioxamine toxicity.

Journal: :The Biochemical journal 1986
A Bomford J Isaac S Roberts A Edwards S Young R Williams

The effect of the iron chelator, desferrioxamine, on transferrin binding, growth rates and the cell cycle was investigated in the human leukaemic cell line, K562. At all concentrations of the chelator (2-50 microM) binding of 125I-transferrin was increased by 24 h and reached a maximum at 72-96 h. Maximum binding (6-8-fold increased) occurred in cells treated with 20 microM-desferrioxamine, in ...

Journal: :iranian journal of blood and cancer 0
sultan sadia irfan syed mohammad kaker jamal uddin zeeshan rozina kidwai asim

background: β-thalassemia is an autosomal hemoglobinopathy with inconsistent universal distribution. among patients with thalassemia diverse non-siderotic complications distinctly influence the attribute of life, including zinc deficiency due to varied etiologies. the objective of the present study was to determine zinc levels in patients with β-thalassemia major and its correlation with matern...

2009
G. Gino Schilirò

Gino Schilirò, Antonio Russo, Cattedra di Ematologia Pediatrica, Istituto di Clinica Pediatrica I, Università di Catania, Viale A. Doria 6, I-95125 Catania (Italy) It is now widely accepted that the best treatment for thalassemia major is a precocious and regular transfusional regimen with the aim of maintaining pretransfusional Hb levels of 10.511 g/dl [1]. Such an approach, by minimizing the ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید